An Open-Label,2-Part Sequential Dose Study Designed to Assess the Absolute Bioavailability, Mass Balance Recovery, Metabolite Profile and Identification of Metabolite Structure for [14C]-AQX-1125 in Healthy Subjects
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Rosiptor (Primary)
- Indications Allergic asthma; Interstitial cystitis
- Focus Pharmacokinetics
- Sponsors Aquinox Pharmaceuticals
- 16 Jun 2017 New trial record